Related posts
Weekly 52-Week Low (or 52-Week High): CEU-T, DGS-T, DCM-T, TK-X and More 52-Week Highs and Lows (Nov 20-26)Most Anticipated Earnings: SLF-T, REAL-T and more Canadian Companies Reporting Earnings this Week (Nov 13-17)Meta sinks marketsThis summary was created by AI, based on 2 opinions in the last 12 months.
The experts agree that Extendicare Inc has had a strong performance year, especially in the long-term care REIT sector. They also note that there may not be much more room for capital gains at the current valuation, and that potential investors may want to wait for a substantial pullback before buying. Additionally, there is a comparison made between EXE and CSH, with CSH being seen as the more conservative option due to its focus on senior homes and the reduction of lower-return investments. Overall, the experts imply that both EXE and CSH have potential, but caution is advised when it comes to investing due to the current market conditions.
EXE operates long-term care facilities which require a lot of capital, while CSH is more senior homes. CSH has been divesting lower-return investments to become more of a pure-play. You can charge whatever rent in a market if there's no competition. The seniors' population keeps growing. CSH is paying down debt, which was high a few years ago. In CSH, the easy money has been made, though. It could be a keeper, or take profits.
How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.
Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.
Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T
In the last year, 2 stock analysts published opinions about EXE-T. 0 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Extendicare Inc.
Extendicare Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Extendicare Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.
On 2024-12-03, Extendicare Inc (EXE-T) stock closed at a price of $10.74.
This has been an extremely good performance year for long-term-care REITs. Not sure there's much more in terms of capital gains from where we are now. Unless substantial pullback, wouldn't buy now.